The cash balance ($5.1M) exceeding the market cap ($2M) creates a potential value dislocation, but the extreme dilution (971K shares on a $2M cap) signals severe shareholder dilution. Monitor for any operational catalysts (clinical trial data, partnership) that could re-rate the stock; absent that, the cash burn rate remains the key risk.
Price Chart
Executive Summary
Autonomix Medical filed an 8-K disclosing a cash balance of approximately $5.1 million and 971,043 shares outstanding as of July 28, 2026, following a recent warrant inducement on July 13, 2026. This is a routine liquidity update providing transparency on the company's cash runway and post-dilution share count. With a $2M market cap, the disclosed cash balance exceeds the entire market value, highlighting an extreme cash-to-market-cap ratio that may attract attention but does not constitute a material operational event.
Key Facts
- Cash balance as of July 28, 2026: approximately $5.1 million.
- Shares outstanding as of July 28, 2026: 971,043.
- Share count includes shares issued in a warrant inducement from July 13, 2026.
- Market capitalization is approximately $2 million, meaning cash exceeds market cap.
Financial Impact
Cash balance of $5.1M exceeds the $2M market cap, implying the market values the operating business at a negative enterprise value. No revenue or earnings data provided.
Risk Factors
- Extreme dilution: 971,043 shares outstanding on a $2M market cap implies a very low per-share price and heavy prior dilution.
- Cash burn rate not disclosed; $5.1M may provide limited runway without additional financing.
- No revenue or operational milestones reported; pre-revenue clinical-stage risk.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 8 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (AMIX) — Batch item 1 | 0001437749-26-024597 |
| Document: 0001437749-26-024597-index-headers.html | 0001437749-26-024597 |
| Document: 0001437749-26-024597-index.html | 0001437749-26-024597 |
| Document: 0001437749-26-024597.txt | 0001437749-26-024597 |
| 8-K Filing (AMIX) — Batch item 5 | 0001437749-26-024597 |
| Document: 0001437749-26-024597-index-headers.html | 0001437749-26-024597 |
| Document: 0001437749-26-024597-index.html | 0001437749-26-024597 |
| Document: 0001437749-26-024597.txt | 0001437749-26-024597 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 13, 2026 13d ago | 3 | $3.01 | awaiting T+20 | — | $2.08 (−30.90%) |
Oct 2, 2026 25d ago | Press Release | $3.78 | awaiting T+20 | — | $2.08 (−44.97%) |
Sep 16, 2026 5w ago | 8-K | $4.12 $3.01 | ▼ −26.94% | ▼ −30.12% | $2.08 (−49.51%) |
Sep 16, 2026 5w ago | EFFECT | $4.12 $3.01 | ▲ +26.94% | ▲ +30.12% | $2.08 (+49.51%) |
Sep 11, 2026 6w ago | 424B5 | $4.33 $3.10 | ▲ +28.41% | ▲ +30.67% | $2.08 (+51.96%) |
Sep 4, 2026 7w ago | S-3 | $4.58 $3.47 | ▲ +24.24% | ▲ +25.95% | $2.08 (+54.59%) |
Aug 26, 2026 8w ago | 8-K | $5.63 $4.07 | ▼ −27.71% | ▼ −27.20% | $2.08 (−63.06%) |
Aug 5, 2026 11w ago | EFFECT | $12.10 $4.50 | ▼ −62.81% | ▼ −62.21% | $2.08 (−82.81%) |
Jul 28, 2026 12w ago | 8-K | $2.75 $7.19 | ▲ +161.45% | ▲ +158.07% | $2.08 (−24.36%) |
Jul 15, 2026 14w ago | 8-K | $4.92 $6.86 | ▼ −39.43% | ▼ −35.81% | $2.08 (+57.72%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers